Harvard Bioscience, Inc. (HBIO) Social Stream



Harvard Bioscience, Inc. (HBIO): $7.66

-0.21 (-2.67%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Harvard Bioscience Inc (HBIO) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering HBIO.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
4 $10 $10 $10 $7.66 30.55%

The Trend in the Analyst Price Target


Over the past 161 days, HBIO's average price target has gone up $1.25.

HBIO reports an average of 29.79% for its upside potential over the past 16 months.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-11 4 10 10 10.00 7.72 29.53%
2021-09-04 4 10 10 10.00 8.24 21.36%
2021-08-28 4 10 10 10.00 8.18 22.25%
2021-08-14 4 10 9 9.75 8.46 15.25%
2021-08-07 4 10 9 9.75 7.93 22.95%
2021-08-05 4 10 9 9.75 8.00 21.88%
2021-08-01 4 10 9 9.75 7.89 23.57%
2021-07-24 4 10 9 9.75 8.15 19.63%
2021-07-17 4 10 9 9.75 7.57 28.8%
2021-07-10 4 10 9 9.75 8.17 19.34%
2021-07-03 4 10 9 9.75 8.23 18.47%
2021-06-26 4 10 9 9.75 7.75 25.81%
2021-06-13 4 10 9 9.75 7.64 27.62%
2021-06-05 4 10 9 9.75 7.13 36.75%
2021-05-22 4 10 9 9.75 7.15 36.36%
2021-05-15 4 10 9 9.75 7.01 39.09%
2021-05-08 4 10 9 9.75 7.34 32.83%
2021-04-25 4 10 7 8.75 6.66 31.38%
2021-04-17 4 10 7 8.75 6.97 25.54%
2021-04-10 4 10 7 8.75 6.53 34%
2021-04-03 4 10 7 8.75 5.44 60.85%
2021-03-20 4 10 7 8.75 6.10 43.44%
2021-03-13 4 9 5 7.50 6.42 16.82%
2021-03-06 4 6 5 5.75 4.24 35.61%
2021-02-27 4 6 5 5.75 4.39 30.98%
2021-02-20 4 6 5 5.75 4.60 25%
2021-02-13 4 6 5 5.75 4.73 21.56%
2021-02-06 4 6 5 5.75 4.88 17.83%
2021-01-30 4 6 5 5.75 4.64 23.92%
2021-01-23 4 6 5 5.75 4.39 30.98%
2021-01-16 4 6 5 5.75 4.34 32.49%
2021-01-09 4 6 5 5.75 4.22 36.26%
2021-01-02 4 6 5 5.75 4.29 34.03%
2020-12-26 4 6 5 5.50 4.08 34.8%
2020-12-19 4 6 5 5.50 4.50 22.22%
2020-12-09 3 6 5 5.33 4.10 30%
2020-12-07 3 6 5 5.33 3.96 34.6%
2020-11-18 2 6 5 5.50 4.00 37.5%
2020-11-06 3 6 5 5.33 3.67 45.23%
2020-10-24 2 5 4 4.50 3.10 45.16%
2020-08-10 2 5 4 4.50 NA NA%
2020-05-28 2 4 4 4.00 NA NA%

HBIO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.38 1 3 0 0 0 4

The Trend in the Broker Recommendations


Over the past 16 months, HBIO's average broker recommendation rating worsened by 0.08.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for HBIO as an investment opportunity.

  • HBIO has a lower variance in analysts' estimates than almost 100% of all US stocks.
  • Harvard Bioscience Inc's average analyst price target is greater than 11.94% of Measuring and Control Equipment stocks.
  • HBIO has a higher upside potential (average analyst target price relative to current price) than 27.64% of Healthcare stocks.
  • The number of analysts covering the stock of HBIO is higher than 35.16% of Healthcare stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Measuring and Control Equipment industry with the ratings most similar to Harvard Bioscience Inc are AMOT, CAMT and CYBE.

What is the outlook for HBIO? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.8203 seconds.